Omega Healthcare Investors (BSP:O2HI34) Beneish M-Score: -2.57 (As of Jun. 25, 2026)


BSP:O2HI34 Omega Healthcare Investors Inc BSP:O2HI34
49 GF Score
Price R$77.02
GF Value R$62.11
Valuation Modestly Overvalued
! 6 Warning Signs
View Full Analysis

What is Omega Healthcare Investors Beneish M-Score?

Omega Healthcare Investors BSP:O2HI34 -0.03% 49 Beneish M-Score is -2.57 as of Jun. 25, 2026. GuruFocus rates BSP:O2HI34 with a GF Score™ of 49/100 and a GF Value™ of R$62.11 (Modestly Overvalued). The stock has 6 warning signs investors should review. Among 765 REITs companies, Omega Healthcare Investors ranks better than 57.39% on this metric.

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -2.57 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for Omega Healthcare Investors's Beneish M-Score or its related term are showing as below:

BSP:O2HI34' s Beneish M-Score Range Over the Past 10 Years
Min: -2.9   Med: -2.6   Max: -2.1
Current: -2.57

During the past 13 years, the highest Beneish M-Score of Omega Healthcare Investors was -2.10. The lowest was -2.90. And the median was -2.60.


Omega Healthcare Investors Beneish M-Score Historical Data

* Premium members only.

The historical data trend for Omega Healthcare Investors's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Omega Healthcare Investors Beneish M-Score Chart

Omega Healthcare Investors Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Beneish M-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2.35 -2.82 -2.56 -2.45 -2.60

Omega Healthcare Investors Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.47 -2.57 -2.60 -2.60 -2.57

BSP:O2HI34 vs DOC, AHR, CTRE: Beneish M-Score Comparison

For the REIT - Healthcare Facilities subindustry, Omega Healthcare Investors's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Omega Healthcare Investors Beneish M-Score vs REITs Industry

For the REITs industry and Real Estate sector, Omega Healthcare Investors's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Omega Healthcare Investors's Beneish M-Score falls into.


BSP:O2HI34
49GF Score
Omega Healthcare Investors Inc BSP:O2HI34
Beneish M-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Omega Healthcare Investors Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Omega Healthcare Investors for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 0.8528+0.528 * 1.0033+0.404 * 1.0293+0.892 * 1.0777+0.115 * 1
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 0.8739+4.679 * -0.037238-0.327 * 0.9495
=-2.67

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Mar26) TTM:Last Year (Mar25) TTM:
Total Receivables was R$10,651 Mil.
Revenue was 1688.925 + 1741.552 + 1671.063 + 1566.722 = R$6,668 Mil.
Gross Profit was 1641.807 + 1717.694 + 1652.276 + 1548.692 = R$6,560 Mil.
Total Current Assets was R$12,149 Mil.
Total Assets was R$53,523 Mil.
Property, Plant and Equipment(Net PPE) was R$0 Mil.
Depreciation, Depletion and Amortization(DDA) was R$1,778 Mil.
Selling, General, & Admin. Expense(SGA) was R$529 Mil.
Total Current Liabilities was R$3,991 Mil.
Long-Term Debt & Capital Lease Obligation was R$21,004 Mil.
Net Income was 789.926 + 899.29 + 963.833 + 757.551 = R$3,411 Mil.
Non Operating Income was 13.566 + 116.381 + 232.54 + 113.201 = R$476 Mil.
Cash Flow from Operations was 1126.989 + 1258.194 + 1215.867 + 1326.916 = R$4,928 Mil.
Total Receivables was R$11,590 Mil.
Revenue was 1593.756 + 1704.119 + 1528.588 + 1361.31 = R$6,188 Mil.
Gross Profit was 1574.691 + 1683.107 + 1508.823 + 1341.112 = R$6,108 Mil.
Total Current Assets was R$13,917 Mil.
Total Assets was R$55,887 Mil.
Property, Plant and Equipment(Net PPE) was R$0 Mil.
Depreciation, Depletion and Amortization(DDA) was R$1,767 Mil.
Selling, General, & Admin. Expense(SGA) was R$562 Mil.
Total Current Liabilities was R$1,886 Mil.
Long-Term Debt & Capital Lease Obligation was R$25,602 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(10651.44 / 6668.262) / (11590.416 / 6187.773)
=1.597334 / 1.873116
=0.8528

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(6107.733 / 6187.773) / (6560.469 / 6668.262)
=0.987065 / 0.983835
=1.0033

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (12149.454 + 0) / 53522.608) / (1 - (13917.103 + 0) / 55886.61)
=0.773003 / 0.750976
=1.0293

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=6668.262 / 6187.773
=1.0777

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(1767.139 / (1767.139 + 0)) / (1778.337 / (1778.337 + 0))
=1 / 1
=1

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(529.264 / 6668.262) / (562.026 / 6187.773)
=0.079371 / 0.090828
=0.8739

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((21003.585 + 3991.456) / 53522.608) / ((25602.027 + 1885.501) / 55886.61)
=0.467 / 0.491845
=0.9495

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(3410.6 - 475.688 - 4927.966) / 53522.608
=-0.037238

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Omega Healthcare Investors has a M-score of -2.67 suggests that the company is unlikely to be a manipulator.

Frequently Asked Questions Learn more about Beneish M-Score →
What does a Beneish M-Score of -2.57 mean?
Omega Healthcare Investors (BSP:O2HI34) has a Beneish M-Score of -2.57 as of Jun. 25, 2026. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Omega Healthcare Investors and its competitors. According to the industry distribution chart, Omega Healthcare Investors ranks #326 out of 765 companies in the REITs industry, placing it in the top 42.6%.
Is Omega Healthcare Investors' Beneish M-Score too high?
Omega Healthcare Investors' current Beneish M-Score is -2.57. Based on the distribution chart, Omega Healthcare Investors ranks #326 out of 765 companies in the REITs industry, which is above the industry midpoint. Overall, Omega Healthcare Investors has a GF Score™ of 49/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Omega Healthcare Investors' Beneish M-Score compare to DOC and AHR?
According to the REITs industry distribution chart, Omega Healthcare Investors ranks #326 out of 765 companies for Beneish M-Score. This puts Omega Healthcare Investors in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beneish M-Score for a REITs company?
A good Beneish M-Score depends on the REITs industry context. However, Beneish M-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beneish M-Score mean?
A high Beneish M-Score can signal that a stock is expensive relative to its fundamentals. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Omega Healthcare Investors and its competitors. Omega Healthcare Investors's current Beneish M-Score is -2.57. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Omega Healthcare Investors stock overvalued right now?
Based on GuruFocus' analysis, Omega Healthcare Investors (BSP:O2HI34) is currently considered Modestly Overvalued. The stock's GF Value™ is R$62.11, compared to a current price of R$77.02 — trading 24% above its estimated fair value. The current Beneish M-Score is -2.57. Omega Healthcare Investors' overall GF Score™ is 49/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beneish M-Score calculated?
Beneish M-Score is calculated from a company's financial statements. For Omega Healthcare Investors (BSP:O2HI34), the current Beneish M-Score is -2.57 as of Jun. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Omega Healthcare Investors (BSP:O2HI34) Overvalued in 2026?

Based on GuruFocus' analysis, Omega Healthcare Investors stock appears to be overvalued. The current stock price of R$77.02 is trading 24% above its estimated GF Value™ of R$62.11. GuruFocus considers Omega Healthcare Investors to be Modestly Overvalued.

Key valuation signals for BSP:O2HI34:

  • Beneish M-Score: -2.57
  • GF Value™: R$62.11 vs. price of R$77.02 (24% above fair value)
  • GF Score™: 49/100 with 6 warning signs

No single metric tells the full story. See the BSP:O2HI34 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Omega Healthcare Investors Business Description

Industry Real EstateREITs
Address 303 International Circle, Suite 200, Hunt Valley, MD, USA, 21030
Omega Healthcare Investors Inc is a real estate investment trust that invests in healthcare-related real estate properties located in the United States (U.S.), the United Kingdom (U.K.), and Canada. The company's objective is to provide attractive returns to investors while serving as the preferred capital partner to its third-party healthcare operating companies and affiliates, as well as other third-party healthcare operators, allowing them to focus on delivering a high level of care to their resident patients. Omega's investment portfolio mainly consists of skilled nursing facilities, assisted living facilities (ALFs), including care homes in the U.K., independent living facilities, rehabilitation and acute care facilities, and continuing care retirement communities.
49GF Score

Get the complete analysis for BSP:O2HI34

Beneish M-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

R$77.02
Price
R$62.11
GF Value